About Florentis Pharmaceuticals Private Limited
Data last updated:
Florentis Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 26 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2011PTC140877. Its GSTIN is 27AABCF9186A1ZN (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.2 Lakh. It is led by directors including Vijaykumar Gangadharrao Pawar and Shriram Parasram Kotkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.55 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹78,894 (net margin 0.5%) and EBITDA of ₹9.66 Lakh (EBITDA margin 6.2%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Florentis Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹68 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website florentispharma.com.
Company details
Contact details
Florentis Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its website is florentispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressCa 1/5 MIDC Chinchwad, Pimpri Chinchwad, Pune, Maharashtra, India – 411019
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Florentis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Florentis Pharmaceuticals operates one associated brand: Florentis Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers custom synthesis, process development, and analytical services for pharmaceutical research. | florentispharma.com |
Business activity
The main business activity of Florentis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Florentis Pharmaceuticals Private Limited, buy the company report.
Financials of Florentis Pharmaceuticals Private Limited
FY 2025 filings availableFlorentis Pharmaceuticals Private Limited reported revenue of ₹1.55 Cr (down 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 29% fall in the latest year. EBITDA fell 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹78,894 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Florentis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Florentis Pharmaceuticals Private Limited
Florentis Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijaykumar Gangadharrao Pawar | Director | 24 Jan 2013 | 13 Years 9 Months | Current |
| Shriram Parasram Kotkar | Director | 26 Sep 2011 | 15 Years 1 Months | Current |
| Laxman Hanmantrao Malge | Director | 26 Sep 2011 | 15 Years 1 Months | Current |
Auditor
Florentis Pharmaceuticals Private Limited is audited by A S MAHAJANI & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A S MAHAJANI & ASSOCIATES | FY 2021 | 131153W |
Shareholding
The shareholding of Florentis Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Florentis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 May 2016 | 100031237 | State Bank of India | ₹68 Lakh | Satisfied |
To see the full charge records of Florentis Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Florentis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Florentis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Florentis Pharmaceuticals Private Limited has a workforce of 7 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
GST
Florentis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCF9186A1ZN | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Florentis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Florentis Pharmaceuticals Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Vijaykumar Gangadharrao Pawar ceased to be Additional Director on 28 Aug 2013.
Frequently asked questions
Florentis Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 26 September 2011 (15+ years old) and is registered under CIN U24100PN2011PTC140877.
Florentis Pharmaceuticals has 3 current directors:
- Vijaykumar Gangadharrao Pawar - Director
- Shriram Parasram Kotkar - Director
- Laxman Hanmantrao Malge - Director
The latest financial statements of Florentis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Florentis Pharmaceuticals is 27AABCF9186A1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Florentis Pharmaceuticals is U24100PN2011PTC140877. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Florentis Pharmaceuticals was incorporated on 26 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Pune.
Vijaykumar Gangadharrao Pawar ceased to be Additional Director on 28 Aug 2013. Vijaykumar Gangadharrao Pawar was appointed as Director on 24 Jan 2013. Laxman Hanmantrao Malge was appointed as Director on 26 Sep 2011. Florentis Pharmaceuticals has 4 board changes on record in total.
Florentis Pharmaceuticals can be reached through the website florentispharma.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Florentis Pharmaceuticals is at Ca 15 MIDC Chinchwad, Pimpri Chinchwad, Pune, Maharashtra, India – 411019.
Florentis Pharmaceuticals operates in the pharma industry, in the pharma contract r and d segment.